News mentioning KEYTRUDA
219 stories
Jun 5, 26Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
May 14, 26Rintatolimod Plus Pembrolizumab and Cisplatin Displays 50% ORR in Recurrent Ovarian Cancer
May 13, 26Biomarker-Driven Treatment Decisions and Managing Progression After Frontline Immunotherapy
May 12, 26Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Cancer
May 12, 26Unmet Needs in Endometrial Cancer